Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots

Journal of Cell Science

Volumn 118, Issue 5, 2005, Pages 1091-1098

  Tokumasu, Fuyuki ^a   Fairhurst, Rick M ^a   Ostera, Graciela R ^a   Brittain, Nathaniel J ^a   Hwang, Jeeseong ^b   Wellems, Thomas E ^a   Dvorak, James A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Autocorrelation; Band 3 clustering; Hemoglobin C; Malaria; Membrane modification; Power spectrum; Quantum dots

Indexed keywords

AUTOANTIBODY; ERYTHROCYTE BAND 3 PROTEIN; HEMOGLOBIN C; QUANTUM DOT;

ANTIGEN RECOGNITION; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE; FLUORESCENCE ANALYSIS; FLUOROSCOPY; GENOTYPE; INNATE IMMUNITY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; SPATIAL AUTOCORRELATION ANALYSIS; THREE DIMENSIONAL IMAGING;

ANIMALS; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; ERYTHROCYTES; GENOTYPE; HEMOGLOBIN C; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALARIA; MICROSCOPY, FLUORESCENCE; MODELS, STATISTICAL; MODELS, THEORETICAL; OXYGEN; PHENOTYPE; PLASMODIUM FALCIPARUM; QUANTUM DOTS;

PLASMODIUM FALCIPARUM;

EID: 16844378031     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01662     Document Type: Article

References (42)

1. Agarwal, A., Guindo, A., Cissoko, Y., Taylor, J. G., Coulibaly, D., Kone, A., Kayentao, K., Djimde, A., Plowe, C. V., Doumbo, O. et al. (2000). Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 96, 2358-2363.
2. Ando, K., Kikugawa, K. and Beppu, M. (1997). Induction of band 3 aggregation in erythrocytes results in anti-band 3 autoantibody binding to the carbohydrate epitopes of band 3. Arch. Biochem. Biophys. 339, 250-257.
3. Arie, T., Fairhurst, R. M., Brittain, N. J., Wellems, T. E. and Dvorak, J. A. (2005). Hemoglobin C modulates the surface topography of Plasmodium falciparum-infected erythrocytes. J. Struct. Biol. (in press).
4. Ayi, K., Turrini, F., Piga, A. and Arese, P. (2004). Enhanced phagocytosis of ring-parasitized mutant erythrocytes. A common mechanism that may explain protection against falciparum-malaria in sickle-trait and beta-thalassemia-trait. Blood 104, 3364-3371.
5. Bosman, G. J. (2004). Erythrocyte aging in sickle cell disease. Cell. Mol. Biol. 50, 81-86.
6. Cappadoro, M., Giribaldi, G., O'Brien, E., Turrini, F., Mannu, F., Ulliers, D., Simula, G., Luzzatto, L. and Arese, P. (1998). Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 92, 2527-2534.
7. Dua, M., Raphael, P., Sijwali, P. S., Rosenthal, P. J. and Hanspal, M. (2001). Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol. Biochem. Parasitol. 116 95-99.
8. Fabry, M. E., Kaul, D. K., Raventos, C., Baez, S., Rieder, R. and Nagel, R. L. (1981). Some aspects of the pathophysiology of homozygous Hb CC erythrocytes. J. Clin. Invest. 67, 1284-1291.
9. Fairhurst, R. M., Fujioka, H., Hayton, K., Collins, K. F. and Wellems, T. E. (2003). Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state. Blood 101, 3309-3315.
10. Giger, U., Sticher, B., Naef, R., Burger, R. and Lutz, H. U. (1995). Naturally occurring human anti-band 3 autoantibodies accelerate clearance of erythrocytes in guinea pigs. Blood 85 1920-1928.
11. Giribaldi, G., Ulliers, D., Mannu, E, Arese, P. and Turrini, F. (2001). Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. Br. J. Haematol. 113, 492-499.
12. Guthrie, N., Crandall, I. E., Marini, S., Fasciglione, G. F. and Sherman, I. W. (1995). Monoclonal antibodies that react with human band 3 residues 542-555 recognize different conformations of this protein in uninfected and Plasmodium falciparum infected erythrocytes. Mol. Cell. Biochem. 144, 117-123.
13. Hanspal, M., Dua, M., Takakuwa, Y., Chishti, A. H. and Mizuno, A. (2002). Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100, 1048-1054.
14. Hebbel, R. P. (1990). The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin. Hematol. 27, 51-69.
15. Hirsch, R. E., Raventos-Suarez, C., Olson, J. A. and Nagel, R. L. (1985). Ligand state of intraerythrocytic circulating HbC crystals in homozygote CC patients. Blood 66, 775-777.
16. Hogh, B., Petersen, E., Crandall, I., Gottschau, A. and Sherman, I. W. (1994). Immune responses to band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high hematocrit value. Infect. Immun. 62, 4362-4366.
17. Hwang, J., Gheber, L. A., Margolis, L. and Edidin, M. (1998). Domains in cell plasma membranes investigated by near-field scanning optical microscopy. Biophys. J. 74, 2184-2190.
18. Jacob, H. S. and Winterhalter, K. H. (1970). The role of hemoglobin heme loss in Heinz body formation: studies with a partially heme-deficient hemoglobin and with genetically unstable hemoglobins. J. Clin. Invest. 49, 2008-2016.
19. Kay, M. M. (1981). Isolation of the phagocytosis-inducing IgG-binding antigen on senescent somatic cells. Nature 289, 491-494.
20. Kay, M. M. (1984). Band 3, the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells age. Monogr. Dev. Biol. 17, 245-253.
21. Kennedy, J. R. (2001). Malaria: a vaccine concept based on sickle haemoglobin's augmentation of an innate autoimmune process to band 3. Int. J. Parasitol. 31, 1275-1277.
22. Liu, S. C., Derick, L. H., Zhai, S. and Palek, J. (1991). Uncoupling of the spectrin-based skeleton from the lipid bilayer in sickled red cells. Science 252, 574-576.
23. Low, P. S., Waugh, S. M., Zinke, K. and Drenckhahn, D. (1985). The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 227, 531-533.
24. Lutz, H. U., Flepp, R. and Stringaro-Wipf, G. (1984). Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein, the major integral membrane protein of human red blood cells. J. Immunol. 133, 2610-2618.
25. Lutz, H. U., Fasler, S., Stammler, P., Bussolino, F. and Arese, P. (1988). Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidatively-stressed and in clearance of senescent red cells. Blood Cells 14, 175-203.
26. Modiano, D., Luoni, G., Sirima, B. S., Simpore, J., Verra, F., Konate, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M. et al. (2001). Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414, 305-308.
27. Rachmilewitz, E. A. (1969). Formation of hemichromes from oxidized hemoglobin subunits. Ann. N. Y. Acad. Sci. 165, 171-184.
28. Rachmilewitz, E. A. (1974). Denaturation of the normal and abnormal hemoglobin molecule. Semin. Hematol. 11, 441-462.
29. Rettig, M. P., Orendorff, C. J., Campanella, E. and Low, P. S. (2001). Effect of pH on the self-association of erythrocyte band 3 in situ. Biochim. Biophys. Acta 1515, 72-81.
30. Rifkind, J. M., Abugo, O., Levy, A. and Heim, J. (1994). Detection, formation, and relevance of hemichromes and hemochromes. Methods Enzymol. 231, 449-480.
31. Roggwiller, E., Betoulle, M. E., Blisnick, T. and Braun Breton, C. (1996). A role for erythrocyte band 3 degradation by the parasite gp76 serine protease in the formation of the parasitophorous vacuole during invasion of erythrocytes by Plasmodium falciparum. Mol. Biochem. Parasitol. 82, 13-24.
32. Rouger, P. and Anstee, D. (1988). 1st International workshop on monoclonal-antibodies against human red blood-cell and related antigens. Vox Sang. 55, 57-61.
33. Schluter, K. and Drenckhahn, D. (1986). Co-clustering of denatured hemoglobin with band 3, its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes. Proc. Natl. Acad. Sci. USA 83, 6137-6141.
34. Schneider, R. G., Takeda, I., Gustavson, L. P. and Alperin, J. B. (1972). Intraerythrocytic precipitations of haemoglobins S and C. Nature New Biol. 235, 88-90.
35. Smith, E. W. and Krevans, J. R. (1959). Clinical manifestations of hemoglobin C disorders. Bull. Johns Hopkins Hosp. 104, 17-43.
36. Tokumasu, F. and Dvorak, J. (2003). Development and application of quantum dots for immunocytochemistry of human erythrocytes. J. Microsc. 211, 256-261.
37. Tokumasu, F., Hwang, J. and Dvorak, J. A. (2004). Heterogeneous molecular distribution in supported multicomponent lipid bilayers. Langmuir 20, 614-618.
38. Turrini, F., Arese, P., Yuan, J. and Low, P. S. (1991). Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J. Biol. Chem. 266, 23611-23617.
39. Waugh, S. M. and Low, P. S. (1985). Hemichrome binding to band 3, nucleation of Heinz bodies on the erythrocyte membrane. Biochemistry 24, 34-39.
40. Waugh, S. M., Willardson, B. M., Kannan, R., Labotka, R. J. and Low, P. S. (1986). Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J. Clin. Invest. 78, 1155-1160.
41. Winterbourn, C. C. and Carrell, R. W. (1974). Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins. J. Clin. Invest. 54, 678-689.
42. Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F. and Bruchez, M. P. (2003). Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41-46.